Hydrochloric Acid

Hydrochloric Acid

SCHEMBL538461

CCCCCCCCCCCCCC[N+](CCO)(CCO)CCCCCCCCCCCCCC.[Cl-]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.68
ALDH1A1 P00352 1/20 0.65
TP53 P04637 1/20 0.65
CYP3A4 P08684 1/20 0.65
ALOX15 P16050 1/20 0.65
TSHR P16473 1/20 0.65
ALOX12 P18054 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
HIF1A Q16665 1/20 0.65
HSD17B10 Q99714 1/20 0.65
SLC22A2 O15244 1/20 0.63
DNM1 Q05193 6/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9125508 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL15538720 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL30472877 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL5389333 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL2772680 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL5352695 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL4892697 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL14777978 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL5350154 1.00 SLC22A1 (0.68) SLC22A1ALDH1A1TP53CYP3A4ALOX15
Hydrochloric Acid SCHEMBL30472878 0.97 SLC22A1 (0.65) SLC22A1ALDH1A1TP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120107389-A1 AMPHOTERIC LIPOSOMAL COMPOSITIONS FOR CELLULAR DELIVERY OF SMALL RNA MOLECULES FOR USE IN RNA INTERFERENCE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-05-03 US claimed
US-9763881-B2 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-09-19 US disclosed
US-20150164797-A1 RICE BRAN-LIPIDS BASED FORMULATION AND PROCESS FOR PREPARATION THEREOF FOR SELECTIVE DELIVERY OF GENES TO CANCER CELLS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-06-18 US disclosed
US-8329681-B2 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals UNIVERSITY OF MASSACHUSETTS (US) 2012-12-11 US disclosed
US-20120107389-A1 AMPHOTERIC LIPOSOMAL COMPOSITIONS FOR CELLULAR DELIVERY OF SMALL RNA MOLECULES FOR USE IN RNA INTERFERENCE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-05-03 US disclosed
EP-2414519-A1 AMPHOTERIC LIPOSOMAL COMPOSITIONS FOR CELLULAR DELIVERY OF SMALL RNA MOLECULES FOR USE IN RNA INTERFERENCE Council of Scientific & Industrial Research (IN) 2012-02-08 EP disclosed
WO-2010113172-A1 AMPHOTERIC LIPOSOMAL COMPOSITIONS FOR CELLULAR DELIVERY OF SMALL RNA MOLECULES FOR USE IN RNA INTERFERENCE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-10-07 WO disclosed
EP-1940775-A2 METHODS AND COMPOSITIONS FOR THE EFFICIENT DELIVERY OF THERAPEUTIC AGENTS TO CELLS AND ANIMALS University of Massachusetts (US) 2008-07-09 EP disclosed
US-20070260055-A1 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-11-08 US disclosed
WO-2007022030-A2 METHODS AND COMPOSITIONS FOR THE EFFICIENT DELIVERY OF THERAPEUTIC AGENTS TO CELLS AND ANIMALS UNIVERSITY OF MASSACHUSETTS (US) 2007-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070260055-A1 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals ABCB4, PIGS, CETP SLC22A1 767/4885ALDH1A1 1072/4885TP53 1011/4885
US-20120107389-A1 AMPHOTERIC LIPOSOMAL COMPOSITIONS FOR CELLULAR DELIVERY OF SMALL RNA MOLECULES FOR USE IN RNA INTERFERENCE ANXA6, DDHD2, ABHD16A SLC22A1 697/4885ALDH1A1 4705/4885TP53 2812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.